Locally Advanced Soft Tissue Sarcoma Completed Phase 1 / 2 Trials for Conatumumab (DB11646)

IndicationStatusPhase
DBCOND0055865 (Locally Advanced Soft Tissue Sarcoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00626704Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue SarcomaTreatment